LaunchPort Welcomes Nanochon
LaunchPort is pleased to announce that Nanochon has joined their City Garage/Baltimore Peninsula location as a LaunchPort Resident. “Over the last three years, Nanochon has
LaunchPort is pleased to announce that Nanochon has joined their City Garage/Baltimore Peninsula location as a LaunchPort Resident. “Over the last three years, Nanochon has
LOS ANGELES-MedTech Innovator, the world’s largest accelerator of medical technology companies, today announced its 2024 Accelerator Cohort. After a competitive selection process with a five percent
WASHINGTON–Nanochon, a Washington, DC-based orthopedic device biotech company has raised $4 million in its series seed prime fundraising round. The round was led by The
Founded in 2016, Nanochon aims to facilitate cartilage replacement and repair for patients suffering from knee injuries. It relies on 3D printing technology, specifically extrusion,
Grand Rapids, Mich., November 27, 2023 — cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage medical device companies with innovative technologies, announced today
To provide the best experiences and remember your preferences, we use technologies like cookies, pixels, and other tracking tools to collect, store, and/or access device information about your device and browsing activities. By using this website or clicking “Accept,” you consent to our use of these technologies. To learn more and to choose whether to accept certain cookies or tracking tools while on the website, please visit the Privacy Statement and Cookie Policy.
Surgeons in British Columbia are conducting a research study to evaluate an investigational device (a new device) to treat articular cartilage lesions in the knee.